VIP for Inflammation
Research, mechanism, dosing, and effectiveness of VIP for inflammation.
Quick Answer
Vasoactive Intestinal Peptide has potent anti-inflammatory effects.
Evidence Level
Human Trials
Typical Dose
Research-stage dosing
Results Timeline
Anti-inflammatory effects in research models
FDA Status
Research Only
How VIP Works for Inflammation
Inhibits pro-inflammatory cytokines and modulates immune responses.
About Inflammation
Reduction of chronic inflammation and inflammatory responses in the body.
Research Evidence
Clinical trials for COVID-19 ARDS showed promising results. Research demonstrates benefits in pulmonary arterial hypertension. Studies show potential for autoimmune conditions like rheumatoid arthritis and inflammatory bowel disease.
Dosing for Inflammation
Recommended Dose
Research-stage dosing
Frequency
1-2x daily, intranasal
Administration
IV infusion, inhaled, or intranasal
Duration
Variable by indication
Note: Vasoactive intestinal peptide. Used for CIRS/mold illness. Intranasal delivery. Requires proper diagnosis first.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Nausea and diarrhea
- •Injection site reactions
- •Headache
- •Dizziness
- •Facial flushing
- •Blood pressure decrease
Frequently Asked Questions
Does VIP help with inflammation?
Vasoactive Intestinal Peptide has potent anti-inflammatory effects.
How does VIP work for inflammation?
Inhibits pro-inflammatory cytokines and modulates immune responses....
What dose of VIP should I use for inflammation?
Research-stage dosing
How long until I see results?
Anti-inflammatory effects in research models
Other Peptides for Inflammation
These peptides are also researched for inflammation.
LL-37
Clinical TrialsA naturally occurring antimicrobial peptide and the only human cathelicidin. Part of the innate immune system with broad-spectrum antimicrobial activity.
Thymosin Alpha-1
Clinical TrialsA naturally occurring thymic peptide that enhances immune function. Approved in over 35 countries for hepatitis B/C and as an immune adjuvant.
KPV
PreclinicalA tripeptide derived from alpha-melanocyte stimulating hormone (α-MSH). Known for potent anti-inflammatory effects, particularly in the gut.
Thymogen
Clinical TrialsA synthetic dipeptide (Glu-Trp) bioregulator derived from Thymalin, a thymus extract. One of Professor Khavinson's key immunomodulatory peptides, shown to stimulate T-lymphocyte development and normalize immune function. Has been used clinically in Russia for immune support.